Catherine Szyman - Edwards Lifesciences Insider

Edwards Lifesciences Corporation -- USA Stock  

USD 110.05  1.53  1.41%

Corporate Vice President Critical Care

Ms. Catherine M. Szyman was Corporationrationrate Vice President, Critical Care of Edwards Lifesciences Corporationrationration since January 2015. Prior to 2015, she was employed for more than 20 years at Medtronic, Inc., where she served as its Senior Vice President and President of Medtronic global diabetes business from 2009 to 2014, overseeing research, development, operations, sales and marketing for Medtronic insulin infusion pumps and continuous glucose monitoring systems. Prior to that, she held a variety of leadership roles at Medtronic, including Senior Vice President of Global Channel Management and Corporationrationrate Strategy and Business Development, Vice President and General Manager of Endovascular Innovations and Vice President of Finance for the Vascular Business
Age: 49  President Since 2015  MBA    
949 250-2500  www.edwards.com
Szyman previously served on the boards of Tornier, Inspire Medical Systems, and the California Healthcare Institute. She graduated from the University of St. Thomas, and earned her MBA from Harvard Business School.

Catherine Szyman Latest Insider Activity

Management Efficiency

The company has Return on Asset (ROA) of 13.17 % which means that for every $100 of asset it generated profit of $13.17. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 26.47 % which means that it produced $26.47 on every 100 dollars invested by current stockholders.
The company reports 1.02 B of total liabilities with total debt to equity ratio (D/E) of 34.5 which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Edwards Lifesciences Corporation has Current Ratio of 3.98 indicating that it is in good position to pay out its debt commitments in time.

Similar Executives

Showing few of many executives

PRESIDENT Since

KarpBaxter International Inc
2016
Nabil ShabshabBecton Dickinson and Company
2011
Brik EyreBaxter International Inc
2017
David NeuAmerisourceBergen Corporation
2015
Samrat KhichiC R Bard Inc
2014
Christopher McGinnisExpress Scripts Holding Company
2015
Betty LarsonC R Bard Inc
2014
Marcus SchabackerBaxter International Inc
2015
Gina ClarkAmerisourceBergen Corporation
2014
Sharon AlterioC R Bard Inc
2009
John DeFordC R Bard Inc
2007
Paul VibertBaxter International Inc
2015
Barbara BrungessAmerisourceBergen Corporation
N/A
Todd GarnerC R Bard Inc
N/A
Giuseppe AccogliBaxter International Inc
2017
Ellen StrahlmanBecton Dickinson and Company
2013
Jill SchaafBaxter International Inc
2015
Keri MattoxAmerisourceBergen Corporation
2017
Sun ParkAmerisourceBergen Corporation
2016
Alberto MasBecton Dickinson and Company
2016
Phyllis AndersonExpress Scripts Holding Company
2015

Entity Summary

Edwards Lifesciences Corporationration offer solutions and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences Corporation (EW) is traded on New York Stock Exchange in USA. It is located in CALIFORNIA, U.S.A and employs 9,800 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Edwards Lifesciences Corporation to your portfolio

Top Management

Edwards Lifesciences Leadership Team
John Cardis, Director
Wesley Schack, Director, MBA
Larry Wood, VP, MBA
Nicholas Valeriani, Director, MBA
Leslie Heisz, Director, MBA
Catherine Szyman, President, MBA
Martha Marsh, Director, MBA
Huimin Wang, President, MBA
Barbara McNeil, Director, Ph.D
Steven Loranger, Director
William Link, Director
Scott Ullem, CFO, MBA
Patrick Verguet, VP, Ph.D
Kieran Gallahue, Director, MBA
Bernard Zovighian, President, MBA
David Erickson, President
Donald Bobo, VP
Michael Mussallem, Chairman, Ph.D

Stock Performance

Edwards Lifesciences Performance Indicators